Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05554003
Title Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study (MeTe)
Acronym MeTe
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Institute of Oncology
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.